Results 31 to 40 of about 14,074 (215)
Non-Hodgkin lymphoma of the thyroid in a patient with hyperthyroidism
Journal of Community Hospital Internal Medicine Perspectives, 2021 Primary thyroid lymphoma is incredibly rare with an annual incidence of approximately 2.1 per million persons, accounting for 2% of thyroid malignancies. One of the only known risk factors is autoimmune thyroid disease, specifically Hashimoto’s, although
Theresa Lanham +3 more
doaj +1 more source
Graves’ ophthalmopathy – thyroid eye disease
Journal of Education, Health and Sport, 2019 Graves’ disease (GD) is an autoimmune disorder that affects thyroid. It is caused by antibody, named thyroid-stimulating immunoglobulin (TIS) that acts like thyroid stimulating hormone (TSH), resulting in thyroid hormone overproduction – condition called
Dagna Siedlecka +3 more
doaj +3 more sources
Hyperglobus and Pseudoptosis in Type 1 Lipogenic Thyroid Eye Disease
American Journal of Ophthalmology Case Reports, 2023 Purpose: We present a case of Type 1 (lipogenic) Thyroid Eye Disease (TED) and our aim is to describe an atypical presentation of a rare orbital process. Observations: A man in his 50s presented with left-sided eyelid drooping.
Amee D. Azad +2 more
doaj +1 more source
Scandinavian Journal of Clinical and Laboratory Investigation, 2019 Jin Ju Kim, Dokyun Kim, Seok Hoon Jeong
exaly +3 more sources
Thyroid Stimulating Immunoglobulin(TSI) in Graves' Disease.
Endocrine Journal, 1998 Yukio Ochi +5 more
openalex +4 more sources
Differential Diagnosis of Thyrotoxicosis by Machine Learning Models with Laboratory Findings
Diagnostics, 2022 Differential diagnosis of thyrotoxicosis is essential because therapeutic approaches differ based on disease etiology. We aimed to perform differential diagnosis of thyrotoxicosis using machine learning algorithms with initial laboratory findings.
Jinyoung Kim +7 more
doaj +1 more source
Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins [PDF]
Clinical and Experimental Immunology, 2010 Summary Thyroid-stimulating immunoglobulins (TSI) are a functional biomarker of Graves' disease (GD). To develop a novel TSI bioassay, a cell line (MC4-CHO-Luc) was bio-engineered to constitutively express a chimeric TSH receptor (TSHR) and constructed with a cyclic adenosine monophosphate (cAMP)-dependent luciferase reporter gene that ...
S D, Lytton +4 more
openaire +2 more sources
Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013 [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2016 PurposeWe aimed to investigate the predictive factors for early response to methimazole (MMI) in pediatric patients with Graves disease (GD).MethodsOur study included 44 pediatric patients who were diagnosed with GD between January 1, 1993, and December ...
Sun Mi Hwang, Min Sun Kim, Dae-Yeol Lee
doaj +1 more source
Journal of the ASEAN Federation of Endocrine Societies, 2021 Patients with triiodothyronine (T3)-predominant Graves’ hyperthyroidism with markedly elevated serum thyroid stimulating immunoglobulin (TSI) levels and massive goitre may display discordant hypothyroxinemia with eutriiodothyroninemia or ...
Brenda Chiang, Yin Chian Kon
doaj +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source